MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT07025564 · SUSPENDED
Trial details
- NCT number
- NCT07025564
- Sponsor
- City of Hope Medical Center
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-24
- Primary completion
- 2028-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.